Office of Justice Programs (OJP)

Comprehensive Opioid Abuse Program (COAP)



  • News &
    Information
  • Funding &
    Availability
  • Training &
    Technical Assistance
  • Related
    Resources
  • Contacts
  • Publications &
    Performance Reports
  • FAQS
  • Archives

Justice Department Is Awarding Almost $320 Million to Combat Opioid Crisis

View a fact sheet to learn about the FY 2018 awards made for BJA-specific programs, including the Comprehensive Opioid Abuse Site-based Program, Innovative Prosecution Solutions, Justice and Mental Health Collaboration Program, and others.


Anticipated FY 2019 Solicitations that Support Law Enforcement

This resource highlights different law enforcement solicitations that are expected to be available from BJA in FY 2019, including opportunities that relate to body-worn cameras, human trafficking investigations, opioids, school safety, and more.


BJA's COAP's Strategic Focus

COAP’s strategic focus on combatting the opioid epidemic reflects the Attorney General’s commitment to reduce the number of fatal overdoses and to protect the American people. Broadly, COAP’s goals are to: (1) reduce opioid abuse and misuse and the number of overdose fatalities; and (2) support the implementation and enhancement of prescription drug monitoring programs (PDMPs).

COAP focuses on systemwide initiatives, as well as innovative approaches, to promote substance abuse treatment and recovery support. These concepts are rooted in the Sequential Intercept Model. The model provides a conceptual framework that communities can use when considering the interface between the criminal justice and substance abuse treatment systems. Within the criminal justice system, there are numerous intercept points, which are opportunities for linkage to services and for prevention of further involvement with the criminal justice system. The model shows the paths an individual may take through the criminal justice system; where the intercept points fall; and areas that communities can target for diversion, engagement, and reentry. In structuring COAP, BJA leaders have focused on effective policy strategies that include the following:

  • Supporting our nation’s first responders and strengthening their partnerships with behavioral health, public health, and agencies that serve crime victims.
  • Expanding diversion programs for nonviolent individuals who abuse illicit and prescription opioids.
  • Implementing and enhancing PDMPs.
  • Encouraging and supporting comprehensive cross-system planning and collaboration among officials who work in law enforcement, pretrial services, the courts, probation and parole, child welfare, reentry, PDMPs, and emergency medical services, as well as health care providers, public health partners, and agencies that provide substance abuse treatment and recovery support services.
  • Developing and implementing strategies to identify and provide treatment and recovery support services to high-frequency utilizers of multiple systems (e.g., health care, child welfare, criminal justice) who have a history of opioid abuse.
  • Increasing the availability of treatment and recovery support services in rural or tribal communities by expanding the use of technology-assisted treatment and recovery support services.
  • Enhancing public safety, behavioral health, and public health information-sharing partnerships that leverage key public health and public safety data sets (e.g., de-identified PDMP data, naloxone administrations, fatal and nonfatal overdose data, drug arrests) to create a holistic view of the environment and develop interventions based on this information.

Coming soon—

In preparation for the FY 2019 COAP solicitation, BJA will provide sample successful applications from FYs 2017 and 2018. The sample applications will show examples of the broad range of programming funded under the six COAP categories.

Funding Options for Prescription Drug Monitoring Programs
To help Prescription Drug Monitoring Programs (PDMPs) identify funding options which may assist them in remaining operational and fulfill their purpose in a time of shrinking state budgets, BJA's PDMP Training and Technical Assistance Center, operated by Brandeis University, has developed a guide to inform PDMP administrators, policymakers, legislative representatives, and other interested stakeholders about funding mechanisms currently in use across the country. The guide also suggests other funding possibilities a PDMP may wish to consider to ensure sustainability and program enhancement.

See More Funding

BJA is pleased to announce the newly developed COAP Resource Center, which houses a wide array of resources, including newsletters, webinars, podcasts, publications, and training opportunities. COAP grantees and opioid abuse/misuse treatment providers can request individualized training and technical assistance in the areas of peer recovery, leveraging of key public health and public safety data sets, reduction of opioid misuse and overdose fatalities, and prescription drug monitoring.

Practitioners and administrators interested in BJA funding can also review detailed program summaries from each grantee awarded under the six categories of the BJA COAP solicitation.

The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) at Brandeis University provides a comprehensive array of services, support, resources, and strategies to PDMPs, federal partners and other stakeholders to further the efforts and effectiveness of PDMPs in combating the misuse, abuse and diversion of prescription drugs.

Additional COAP TTA provider websites are forthcoming for the Institute for Intergovernmental Research, Advocates for Human Potential, and Altarum Institute.

Tara Kunkel
Senior Drug Policy Officer (IPA)
202-616-0690
E-mail: tara.kunkel@ojp.usdoj.gov

Tim Jeffries
Policy Advisor
202-616-7385
E-mail: timothy.jeffries@usdoj.gov

Comprehensive Opioid Abuse Program Newsletter, First Edition 2019, BJA-Sponsored, February 2019. This newsletter highlights information about and activities associated with BJA's Comprehensive Opioid Abuse Program (COAP), as well as details on upcoming events and training and technical assistance opportunities.
PDF

Comprehensive Opioid Abuse Program Newsletter, Second Edition 2018, BJA-Sponsored, August 2018. This newsletter highlights information about and activities associated with BJA's Comprehensive Opioid Abuse Program (COAP), as well as details on upcoming events and training and technical assistance opportunities.
PDF

Comprehensive Opioid Abuse Program Newsletter, First Quarter 2018, BJA-Sponsored, July 2018. This newsletter highlights information about and activities associated with BJA's Comprehensive Opioid Abuse Program (COAP), as well as details on upcoming events and training and technical assistance opportunities.
PDF

2017 BJA Harold Rogers Prescription Drug Monitoring Program National Meeting: Agenda and Presentations, BJA-Sponsored, September 2017. This resource presents access to the presentations that took place during the September 2017 BJA Harold Rogers Prescription Drug Monitoring Program National Meeting.
HTML

2017 Prescription Drug Monitoring Program Introduced and Enacted Legislation and Regulations, BJA-Sponsored, August 2017. This resource presents details of federal- and state-level legislative bills and regulations introduced or enacted in 2017 that relate to prescription drug monitoring programs.
PDF

Tracking PDMP Enhancement: The Best Practice Checklist, BJA-Sponsored, March 2017. This report documents the development of the prescription drug monitoring program (PDMP) best practice checklist, a tool for tracking the adoption of practices over time by PDMPs, both individually and collectively.
PDF

Enhancing PDMPs: A Comparison of Changes 2010 to 2016, BJA-Sponsored, December 2016. Using data from four assessments and information received from prescription drug monitoring programs (PDMPs) separate and subsequent to the assessments, this guide details the changes and evolution PDMPs have undergone between 2010 and 2016 as they apply to selected best practices.
PDF

PDMP Suggested Practices To Ensure Pharmacy Compliance and Improve Data Integrity, BJA-Sponsored, April 2015. This guide details the areas where prescription data errors may occur, some procedures prescription drug monitoring programs (PDMPs) employ to detect those errors, and steps to ensure the erroneous data is corrected. Also provided are suggestions for prescribers, dispensers, and other stakeholders to consider to prevent data errors from occurring.
PDF

Call to Action and Issue Brief: Justice System Use of Prescription Drug Monitoring Programs - Addressing the Nation's Prescription Drug and Opioid Abuse Epidemic, BJA-Sponsored, January 2015. This resource serves as an educational tool and call to action, underscoring the value of the justice enterprise's participation in prescription drug monitoring programs from both the public safety and the public health perspective.
PDF

RxStat Technical Assistance Manual, BJA-Sponsored, September 2014. RxStat is a model for advancing a shared understanding of the patterns and characteristics of problem drug use – including prescription opioid misuse – in a local jurisdiction. This manual is designed to support local jurisdictions in the establishment of an RxStat initiative.
PDF

More BJA Publications

Grant Awards:

Frequently Asked Questions about the Office of Justice Programs (OJP) Bureau of Justice Assistance (BJA) Fiscal Year (FY) 2017 Comprehensive Opioid Abuse Site-based and Training and Technical Assistance Grant Programs

PDMP TTAC Newsletters:


Announcement:

Upcoming Webinar: First Responder Burnout Prevention

Register to participate in First Responder Burnout Prevention, taking place October 11, 2018, at 1 p.m. ET. Offered as part of the Comprehensive Opioid Abuse Program Webinar Series, this session will examine the causes of first responder burnout with consideration given to stresses arising from response to the opioid epidemic.


Deadline Extended: Comprehensive Opioid Abuse Site-based Program

The closing date for the FY 2018 Comprehensive Opioid Abuse Site-based Program has been extended from June 7, 2018, to June 18, 2018. This program is designed to support first responders and provide for the needs of crime victims; support diversion programs for non-violent individuals who abuse illicit and prescription opioids; implement and enhance prescription drug monitoring programs; promote cross-system planning and coordination of service delivery; and reduce the incidence of fatal overdoses associated with opioid use.


Comprehensive Opioid Abuse Site-based Program

BJA has released the FY 2018 Comprehensive Opioid Abuse Site-based Program solicitation. This program is designed to support first responders and provide for the needs of crime victims; support diversion programs for non-violent individuals who abuse illicit and prescription opioids; implement and enhance prescription drug monitoring programs; promote cross-system planning and coordination of service delivery; and reduce the incidence of fatal overdoses associated with opioid use. Deadline extended from June 7 to June 18, 2018.


Responding to BJA’s FY 2018 Comprehensive Opioid Abuse Program (COAP) Solicitation

On May 15, from 1:00-2:30 p.m. ET, BJA will review the FY 2018 COAP solicitation and grant application process during the "Responding to BJA’s FY 2018 COAP Solicitation" webinar. Access the FY 2018 COAP solicitation and register today to participate in the webinar.


Responding to the Opioid Crisis: National and Local Approaches

On January 17, 2018, at 2 p.m. ET, BJA staff will be among the speakers in the Responding to the Opioid Crisis: National and Local Approaches webinar. During this event, federal and local solutions will be discussed and an overview of related BJA initiatives will be presented. Learn more and register to participate in the webinar.


Opioid Abuse Program TTA Solicitation Available

BJA has released the FY 2017 Comprehensive Opioid Abuse Program Training and Technical Assistance (TTA) Program grant announcement. This program provides resources to state, local, and tribal governments to intervene with persons with substance use disorders. Apply by: April 25, 2017.


Funding Available for Comprehensive Opioid Abuse Site-based Program

BJA has released the FY 2017 Comprehensive Opioid Abuse Site-based Program funding opportunity. This program provides resources to state, local, and tribal governments to intervene with persons with substance use disorders. Apply by: April 25, 2017.


Harold Rogers Prescription Drug Monitoring Program Solicitation Released

BJA is seeking applications for the FY 2016 Harold Rogers Prescription Drug Monitoring Program. This program provides resources to plan, implement, and enhance prescription drug monitoring programs to prevent and reduce misuse and abuse of prescription drugs and aid in investigations of pharmaceutical crime. Applications are due by April 26, 2016.


Justice System Use of PDMPs

BJA and the Global Justice Information Sharing Initiative have released a new resource: Call to Action and Issue Brief: Justice System Use of Prescription Drug Monitoring Programs—Addressing the Nation’s Prescription Drug and Opioid Abuse Epidemic. This resource offers justice practitioners and policymakers valuable, practical, hands-on sections such as the PDMP best-practices checklist, a compendium of resources and references, and next steps to help them address this critical public safety and public health challenge.


Funding:

Comprehensive Opioid Abuse Site-based Program
Application Deadline: 06/18/2018, 11:59 PM
BJA, in partnership with the Office for Victims of Crime (OVC), is seeking applications to plan and implement comprehensive programs in response to the growing opioid epidemic.
Solicitation  Webinar


Comprehensive Opioid Abuse Program Training and Technical Assistance (TTA) Program FY 2017 Competitive Grant Announcement
Application Deadline: 04/25/2017, 11:59 PM
BJA is seeking applications to plan and implement comprehensive strategies in response to the growing opioid epidemic. This program furthers the Department’s mission by providing resources to state, local, and tribal governments to intervene with persons with substance-use disorders.
Solicitation


Comprehensive Opioid Abuse Site-based Program FY 2017 Competitive Grant Announcement
Application Deadline: 04/25/2017, 11:59 PM
BJA is seeking applications to plan and implement comprehensive strategies in response to the growing opioid epidemic. This program furthers the Department’s mission by providing resources to state, local, and tribal governments to intervene with persons with substance use disorders.
Solicitation


Harold Rogers Prescription Drug Monitoring Program FY 2016 Competitive Grant Announcement
Application Deadline: 04/26/2016, 11:59 PM
BJA is seeking applications for funding under the Harold Rogers Prescription Drug Monitoring Program (PDMP). This program furthers the Department’s mission by providing resources to plan, implement, and enhance prescription drug monitoring programs to prevent and reduce misuse and abuse of prescription drugs and aid in investigations of pharmaceutical crime.
Solicitation


Harold Rogers Prescription Drug Monitoring Program FY 2015 Competitive Grant Announcement
Application Deadline: 05/28/2015, 11:59 PM
This program provides resources to plan, implement, and enhance prescription drug monitoring programs to prevent and reduce misuse and abuse of prescription drugs and aid in investigations of pharmaceutical crime
Solicitation


Harold Rogers Prescription Drug Monitoring Program FY 2014 Competitive Grant Announcement
Application Deadline: 05/06/2014, 11:59 PM
PDMP provides resources to plan, implement, and enhance prescription drug monitoring programs to prevent and reduce misuse and abuse of prescription drugs and aid in investigations of pharmaceutical crime
Solicitation


Harold Rogers Prescription Drug Monitoring National Training and Technical Assistance Program FY 2014 Competitive Grant Announcement
Application Deadline: 05/06/2014, 11:59 PM
This program will assist states with developing effective strategies for planning, implementing, or enhancing prescription drug monitoring programs.
Solicitation


Harold Rogers Prescription Drug Monitoring Program FY 2013 Competitive Grant Announcement
Application Deadline: 05/02/2013, 11:59 PM
This program provides resources to plan, implement, and enhance prescription drug monitoring programs to prevent and reduce misuse and abuse of prescription drugs and to aid in investigations of pharmaceutical crime.
Solicitation


Harold Rogers Prescription Drug Monitoring Program FY 2012 Competitive Grant Announcement
Application Deadline: 05/08/2012, 11:59 PM
This program provides resources to plan, implement, and enhance prescription drug monitoring programs to prevent and reduce misuse and abuse of prescription drugs and to aid in investigations of pharmaceutical crime.
Solicitation


Harold Rogers Prescription Drug Monitoring Program FY 2011 Competitive Grant Announcement
Application Deadline: 05/19/2011, 11:59 PM
This program enhances the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled chemical products through a centralized database administered by an authorized state agency.
Solicitation


Harold Rogers Prescription Drug Monitoring National Training and Technical Assistance Program FY 2011 Competitive Grant Announcement
Application Deadline: 05/19/2011, 11:59 PM
This program supports the Harold Rogers Prescription Drug Monitoring Discretionary Grant Program.
Solicitation


Harold Rogers Prescription Drug Monitoring Program FY 2010 Competitive Grant Announcement
Application Deadline: 04/01/2010, 07:59 PM
This program enhances the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled listed chemical products through a centralized database administered by an authorized state agency.
Solicitation  2010 Frequently Asked Questions  Sample Logic Model


Harold Rogers Prescription Drug Monitoring Program FY 2009 Competitive Grant Announcement
Application Deadline: 02/12/2009, 07:59 PM
This program enhances the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data through a centralized database administered by an authorized state agency.
Solicitation


Harold Rogers Prescription Drug Monitoring Training and Technical Assistance Program FY 2008 Competitive Grant Announcement
Application Deadline: 05/15/2008, 07:59 PM
This program supports the Harold Rogers Prescription Drug Monitoring Discretionary Grant Program.
Solicitation


Developing and Enhancing Prescription Drug Monitoring Programs FY 2008 Competitive Grant Announcement
Application Deadline: 02/14/2008, 07:59 PM
PDMP enhances the capacity of regulatory and law enforcement agencies to collect and analyze controlled substance prescription data through a centralized database administered by an authorized state agency.
Solicitation  Frequently Asked Questions


Developing and Enhancing Prescription Drug Monitoring Programs (PDMP) FY 2007 Competitive Grant Announcement
Application Deadline: 01/11/2007, 07:59 PM
PDMPs enhance the capacity of regulatory and law enforcement agencies to collect and analyze controlled substance prescription data through a centralized database administered by an authorized state agency.
Solicitation  Frequently Asked Questions


Developing and Enhancing Prescription Drug Monitoring Programs (PDMPs) FY 2006 Competitive Grant Announcement
Application Deadline: 12/15/2005, 07:59 PM
This program enhances the capacity of regulatory and law enforcement agencies to collect and analyze controlled substance prescription data through a centralized database administered by an authorized state agency.
Solicitation


Developing and Enhancing Prescription Drug Monitoring Programs: FY 2005 Competitive Grant Announcement
Application Deadline: 01/19/2005, 11:59 PM
These programs are designed to help prevent and detect the diversion and abuse of pharmaceutical controlled substances, particularly at the retail level where no other automated information collection system exists.
Solicitation

 

MY BJA

Welcome, (Sign In or Register). padlock icon

TOOLS

CONNECT

Stay in contact with BJA via Twitter Visit BJA on Facebook Subscribe to the BJA RSS feed Listen to BJA Podcasts

Enter City, State or ZIP
Back to Top